Literature DB >> 21986877

Hypothesis review: are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder?

K O Schubert1, M Föcking, J H M Prehn, D R Cotter.   

Abstract

Clathrin-mediated endocytosis (CME) is the best-characterized mechanism governing cellular membrane and protein trafficking. In this hypothesis review, we integrate recent evidence implicating CME and related cellular trafficking mechanisms in the pathophysiology of psychotic disorders such as schizophrenia and bipolar disorder. The evidence includes proteomic and genomic findings implicating proteins and genes of the clathrin interactome. Additionally, several important candidate genes for schizophrenia, such as dysbindin, are involved in processes closely linked to CME and membrane trafficking. We discuss that key aspects of psychosis neuropathology such as synaptic dysfunction, white matter changes and aberrant neurodevelopment are all influenced by clathrin-dependent processes, and that other cellular trafficking mechanisms previously linked to psychoses interact with the clathrin interactome in important ways. Furthermore, many antipsychotic drugs have been shown to affect clathrin-interacting proteins. We propose that the targeted pharmacological manipulation of the clathrin interactome may offer fruitful opportunities for novel treatments of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21986877     DOI: 10.1038/mp.2011.123

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  38 in total

1.  Identification of putative second genetic hits in schizophrenia carriers of high-risk copy number variants and resequencing in additional samples.

Authors:  Julio Rodríguez-López; Beatriz Sobrino; Jorge Amigo; Noa Carrera; Julio Brenlla; Santiago Agra; Eduardo Paz; Ángel Carracedo; Mario Páramo; Manuel Arrojo; Javier Costas
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-04-18       Impact factor: 5.270

2.  Proteomics tackling schizophrenia as a pathway disorder.

Authors:  Daniel Martins-de-Souza
Journal:  Schizophr Bull       Date:  2012-07-30       Impact factor: 9.306

Review 3.  Genetics of schizophrenia from a clinicial perspective.

Authors:  Prachi Kukshal; B K Thelma; Vishwajit L Nimgaonkar; Smita N Deshpande
Journal:  Int Rev Psychiatry       Date:  2012-10

4.  GRASP1 Regulates Synaptic Plasticity and Learning through Endosomal Recycling of AMPA Receptors.

Authors:  Shu-Ling Chiu; Graham Hugh Diering; Bing Ye; Kogo Takamiya; Chih-Ming Chen; Yuwu Jiang; Tejasvi Niranjan; Charles E Schwartz; Tao Wang; Richard L Huganir
Journal:  Neuron       Date:  2017-03-09       Impact factor: 17.173

5.  Transcription factor Sp4 regulates expression of nervous wreck 2 to control NMDAR1 levels and dendrite patterning.

Authors:  Xinxin Sun; Raquel Pinacho; Gregory Saia; Diana Punko; J Javier Meana; Belén Ramos; Grace Gill
Journal:  Dev Neurobiol       Date:  2014-07-22       Impact factor: 3.964

6.  Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia.

Authors:  M Föcking; L M Lopez; J A English; P Dicker; A Wolff; E Brindley; K Wynne; G Cagney; D R Cotter
Journal:  Mol Psychiatry       Date:  2014-07-22       Impact factor: 15.992

Review 7.  Clozapine as a Model for Antipsychotic Development.

Authors:  Frederick C Nucifora; Marina Mihaljevic; Brian J Lee; Akira Sawa
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

8.  Increased density of prohibitin-immunoreactive oligodendrocytes in the dorsolateral prefrontal white matter of subjects with schizophrenia suggests extraneuronal roles for the protein in the disease.

Authors:  Hans-Gert Bernstein; Karl-Heinz Smalla; Diana Dürrschmidt; Gerburg Keilhoff; Henrik Dobrowolny; Johann Steiner; Andrea Schmitt; Michael R Kreutz; Bernhard Bogerts
Journal:  Neuromolecular Med       Date:  2012-06-19       Impact factor: 3.843

9.  Dysbindin-1 contributes to prefrontal cortical dendritic arbor pathology in schizophrenia.

Authors:  Glenn T Konopaske; Darrick T Balu; Kendall T Presti; Grace Chan; Francine M Benes; Joseph T Coyle
Journal:  Schizophr Res       Date:  2018-05-11       Impact factor: 4.939

Review 10.  Losing your inhibition: linking cortical GABAergic interneurons to schizophrenia.

Authors:  Melis Inan; Timothy J Petros; Stewart A Anderson
Journal:  Neurobiol Dis       Date:  2012-11-29       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.